We got some efficacies in treating early diabetic nephropathy with Xuezhikang Capsule.
我们运用血脂康胶囊治疗早期糖尿肾病，取得一定疗效。
To investigate the clinical effects of calcium dobesilate on early diabetic nephropathy.
目的观察羟苯磺酸钙治疗早期糖尿病肾病的临床疗效。
Objective To investigate the effect of Tongmai oral liquid on the early diabetic nephropathy.
目的研究通脉口服液防治早期糖尿病肾病的作用机制。
For example, if you have early diabetic nephropathy, you can take medication to prevent further damage.
举例来说，如果你出现了早期的糖尿病肾脏病变，可以服药防止其恶化。
Conclusions Simvastatin can protect the kidney, and delay the progression of early diabetic nephropathy.
结论辛伐他汀对早期DN患者有肾脏保护作用，能延缓其进展为终末期肾病。
Objective: to observe the clinical effect of Jinqi Capsules to treat the early diabetic nephropathy (DN).
目的：观察中药金芪胶囊治疗早期糖尿病肾病(DN)的临床疗效。
Objective To evaluate the value of color Doppler ultrasound in the diagnosis of early diabetic nephropathy.
目的探讨彩色多普勒超声对诊断早期糖尿病肾病的临床价值。
Objective To explore the changes and significance of retinol-binding protein (RBP) in early diabetic nephropathy (DN).
目的探讨糖尿病肾病(DN)病人早期尿视黄醇结合蛋白(rbp)的变化及意义。
Objective To study the significance of the blood urea nitrogen and serum creatinine in the diagnosis of early diabetic nephropathy.
目的：探讨血清尿素氮及血清肌酐对早期糖尿病肾病的诊断价值。
Results Survey confirmed 56 cases of early diabetic nephropathy, a good control of blood glucose and blood pressure, blood lipid levels.
结果普查确诊56例早期糖尿病肾病患者，给予控制血糖和血压、血脂水平。
Objective To study the mechanism of preventing proteinuria by traditional Chinese medicine YSGJD in early diabetic nephropathy (DN) in rats.
目的探讨中药益肾固精方对大鼠早期糖尿病肾病(DN)蛋白尿的防治及可能机制。
All these suggested that the determination of urinary NAG activity can be used as a sensitive indicator predicting early diabetic nephropathy.
提示尿nag活性测定可作为间接反映肾小球滤过膜功能、筛查糖尿病早期肾病的一项敏感指标。
Objective It is to observe the therapeutic effect of Xiaoke Baoshen Decoction(XBD) combined with Benazepril on early diabetic nephropathy(EDN).
目的观察中药消渴保肾汤与贝那普利联合治疗早期糖尿病肾病的疗效。
To observe and analyze the China Ixeris combine with alprostadil in the treatment of early diabetic nephropathy and summarize its clinical value.
观察和分析苦碟子联合前列地尔治疗早期糖尿病肾病的临床疗效，总结其临床价值。
Objective To study the role of Urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) for diagnosis of early diabetic nephropathy.
目的探讨尿白蛋白排泄率(UAER)和肾小球滤过率(GFR)在早期糖尿病肾病的诊断价值。
Objective: To systematically observe the clinical efficacy and security of Shen Qi Tang Shen an decoction in the treatment of early diabetic nephropathy.
目的系统观察参芪糖肾安汤治疗早期糖尿病肾病的临床疗效和安全性。
Objective:To investigate the significance of renal tubular dysfunction in patients with early diabetic nephropathy and the effect of interference treatment of Valsartan.
目的：探讨肾小管功能损害在早期糖尿病肾病中的意义及缬沙坦干预治疗对其影响。
Objective To evaluate the changes of glomerular filtration rate (GFR), effective renal plasma flow (ERPF) and microalbuminuria in early diabetic nephropathy (DN) and their correlation.
目的探讨早期糖尿病肾病（DN）肾小球滤过率（GFR）和肾有效血浆流量（ERPF）与尿微量蛋白的变化特点及其相互关系。
Results: Tangshen decoction could reduce the level of blood sugar and urine albumen, improve the level of SOD and reduce the content of MDA in kidney tissue of early diabetic nephropathy rats.
结果糖肾汤能降低早期糖尿病肾病模型大鼠血糖、尿微量白蛋白、尿蛋白，提高肾组织SOD水平，减少肾组织MDA含量。
Objective To explore the value of combined measurement of urinary five proteins in diagnosing diabetic nephropathy early.
目的探讨联合检测尿五种蛋白对早期诊断糖尿病肾病的临床价值。
Conclusion Urinary five proteins combination measurement have clinical value for the diagnosis of diabetic nephropathy early.
结论尿五种蛋白联合检测对糖尿病肾病的早期诊断具有较大的临床价值。
Serum cystatin C; Diabetic nephropathy; Early diagnosis.
铩血清胱抑素C；糖尿病肾病；早期诊断。
Objective: To observe the effect of Tangke decoction on glomerular filtration rate (GFR) in early nephropathy diabetic rats.
目的：观察糖克煎剂对大鼠糖尿病肾病早期滤过率影响。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Objective: To evaluate the efficacy and safety of the pancreatic kininogenase tablets in treating early stage diabetic nephropathy.
目的：评价胰激肽原酶片治疗早期糖尿病肾病患者的疗效和安全性。
Objective To investigate the impact of low molecular heparin(LMH)and valsartan on urine albumin excretion rate(UAER)in patients with early type-2 diabetic nephropathy(DN).
目的观察低分子肝素联合缬沙坦对2型早期糖尿病肾病（DN）患者尿白蛋白排泄率（UAER）的影响。
And having an early diagnosis and treat to DM can improve case's living quality and decrease the incidence of diabetic nephropathy and death rate.
早期诊断治疗糖尿病可提高糖尿病人生存质量，减少糖尿病肾病的发生，降低病死率。
Microalbuminuria is the first sign of the pathogenesis of diabetic nephropathy. It is also an important marker of early development of cardiovascular disease and can indicate microvascular disease.
微量白蛋白尿是糖尿病肾病发病的首要指征，也是早期出现心血管疾病的重要指征之一，可提示微血管病变。
Methods: 60 cases of early phase diabetic nephropathy patients were divided randomly into two groups, 30 in the therapeutic group and 30 in the control group.
方法：将60例早期糖尿病肾病患者随机分为治疗组与对照组，每组30例。
Objective: to study the influence of valsartan to correlated inflammatory cytokine in early stage of type 2 diabetic nephropathy and the protection to diabetic nephropathy.
目的：观察缬沙坦对2型糖尿病早期肾病相关炎症因子的影响及对糖尿病肾病的保护作用。
应用推荐